Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Xanax
Generic name / active ingredient
alprazolam
Dosage-form class
Oral tablets (C-IV): 0.25 mg, 0.5 mg, 1 mg and 2 mg (as listed in the dated public label; four exact 100-tablet bottle identities are kept separate; not merged with XANAX XR)
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check XANAX, alprazolam, the exact dosage form, labelled strength per tablet and target market first. A shared “sleep/sedation/anxiety” description does not prove another medicine, strength or extended-release form can be self-substituted.
  • The FDA label carries important warnings about use with opioids, alcohol or other central-nervous-system depressants. With pain, cough, sleep, allergy, alcohol or multiple psychiatric products at home, have a pharmacist or clinician review the complete list and actual use.
  • The label warns about dependence, abuse, misuse and risks after abrupt reduction or discontinuation. Do not self-increase, share, irregularly alternate or suddenly stop because of feeling better, drowsiness or concern about adverse effects; tapering and discontinuation need a plan from the prescribing team.
  • With older age, falls, breathing problems, altered awareness or multiple medicines, risk assessment cannot come from a webpage alone. For severe drowsiness, slowed breathing, altered consciousness or another acute concern, use local emergency and medical guidance promptly.

Reviewed presentation examples — compare every field

  • Alprazolam 0.25 mg per tablet; 100-tablet bottleNDC 0009-0029-01
  • Alprazolam 0.5 mg per tablet; 100-tablet bottleNDC 0009-0055-01
  • Alprazolam 1 mg per tablet; 100-tablet bottleNDC 0009-0090-01
  • Alprazolam 2 mg per tablet; 100-tablet bottleNDC 0009-0094-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image